Comparison of two types of aerobic and resistance training on on sarcopenia indexes (SI) in diabetic patients

Comparison of effects of two types of aerobic and resistance training on sarcopenia indexes (SI) in diabetic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181006041252N17

Enrollment

Registered

2019-12-01

Start date

2019-04-14

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group 1: Patients in this group perform resistance training for 8 weeks and 3 sessions per week including 10 minutes warm-up, 40 minutes core exercise and 10 minutes cool-

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with low physical activity based on GPAQ standard questionnaire Metformin consumption for at least 2 years Having diabetes for 4 to 6 years Fasting blood glucose above 126 mg /dL Age between 40 and 70 years

Exclusion criteria

Exclusion criteria: Patients with a high blood glucose of 250 mg/dl Having cardiac or musculoskeletal problems precludes activity Using drugs affecting the nervous and vascular systems

Design outcomes

Primary

Measure	Time frame
Determine the level of testosterone. Timepoint: At the beginning of the study (before the intervention) and 2 months after the beginning of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determine Sarcopenia Index (SI). Timepoint: At the beginning of the study (before the intervention) and 2 months after the beginning of the training program. Method of measurement: (Serum Creatinine value/Cystatin C value) × 100. Use of Luminescence quantitative and ELISA methods to measure serum levels.;Determination of Waist to hip ratio (WHR). Timepoint: At the beginning of the study (before the intervention) and 2 months after the beginning of the training program. Method of measurement: Use of meters.	—

Measure

Time frame

Determine the level of testosterone. Timepoint: At the beginning of the study (before the intervention) and 2 months after the beginning of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determine Sarcopenia Index (SI). Timepoint: At the beginning of the study (before the intervention) and 2 months after the beginning of the training program. Method of measurement: (Serum Creatinine value/Cystatin C value) × 100. Use of Luminescence quantitative and ELISA methods to measure serum levels.;Determination of Waist to hip ratio (WHR). Timepoint: At the beginning of the study (before the intervention) and 2 months after the beginning of the training program. Method of measurement: Use of meters.

—

Secondary

Measure	Time frame
Determination of Fasting blood sugar (FBS). Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determination of Hemoglobin A1C. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determination of the sense of touch. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Rub round bottom pin, cotton or brush.;Determination of the limbs blood flow. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Ankle-Brachial Index (ABI) device.;Determination of body mass index. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of standard meters and scales.	—

Measure

Time frame

Determination of Fasting blood sugar (FBS). Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determination of Hemoglobin A1C. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determination of the sense of touch. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Rub round bottom pin, cotton or brush.;Determination of the limbs blood flow. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of Ankle-Brachial Index (ABI) device.;Determination of body mass index. Timepoint: At the beginning of the study (before the intervention) and 2 months after the start of the training program. Method of measurement: Use of standard meters and scales.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Sahebkar

Sabzevar University of Medical Sciences

Mohammad.sahebkar66@yahoo.com+98 51 4401 8337

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026